This task order is to develop an optimized phase 1 cgmp manufacturing process for lipid nanoparticle (LNP) fabrication that enable covalent coupling of an HIV-1 ENV trimer to the surface of the LNP. A…
Active Awarded Last action
- Contract number
- 75N93021F00239
- Awardee
-
International Aids Vaccine Initiative Inc. UEI ZEJBC8JQM3P5
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $2,250,342
Award facts
- Opportunity
-
- 75N93021F00239 Solicitation number
- Contract value 100% obligated
- $2,250,341.50 Current and potential, with all options
- Completion date 73% complete
- Current and potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- New York, NY 10004, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$403 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Funding Only Action | $382,052 | |
| Definitize Change Order | $252,960 | |
| Other Administrative Action | $0 | |
| Change Order | $19,938 | |
| Original award | $1,595,794 |
About this award
The National Institute of Allergy and Infectious Diseases issued a delivery order to International AIDS Vaccine Initiative Inc. on September 15, 2021, with a ceiling value of $2,250,341.50, to develop an optimized Phase 1 cGMP manufacturing process for lipid nanoparticle fabrication enabling covalent coupling of an HIV-1 envelope trimer to the lipid nanoparticle surface, with a non-GMP process run of drug product to follow. The order was issued under a cost-plus-fixed-fee pricing structure with no set-aside designation and carries an ultimate completion date of August 31, 2028.
Place of performance is New York, NY. Government-invoiced labor across reported fiscal years shows 1.3 FTEs and 2,697 contractor hours in FY2024, the most recent reported year, at a derived blended rate of $131.95 per hour. FY2024 teaming depth included one subcontractor accounting for 58 percent of contractor hours. Pricing declined from $212.25 per hour in FY2022 to $122.06 per hour in FY2023 before recovering slightly in FY2024, reflecting the order's active development phase.
Description
This task order is to develop an optimized phase 1 cgmp manufacturing process for lipid nanoparticle (LNP) fabrication that enable covalent coupling of an HIV-1 ENV trimer to the surface of the LNP. A non-GMP process run of drug product shall be perf
Quick answers
Who was awarded contract 75N93021F00239?
75N93021F00239 was awarded to International Aids Vaccine Initiative Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 15, 2021.
How much is contract 75N93021F00239 worth?
The government has obligated $2,250,342 on 75N93021F00239.
Is contract 75N93021F00239 an order under another contract?
Yes. 75N93021F00239 is a delivery order under HHSN272201600011I, an indefinite delivery contract.
Was contract 75N93021F00239 competed?
The extent of competition for 75N93021F00239 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award